Compare Revvity Inc (RVTY) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Verisign, Inc. — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while Verisign, Inc. trades at $277.5 (market cap $25.26B). The key difference: Verisign, Inc. is far larger — about 2.1× Revvity Inc's market cap, and Verisign, Inc. pays the higher dividend (1.17%). Which is the better fit depends on your goals.
| RVTY | VRSN | |
|---|---|---|
Market Cap | $11.87B | $25.26B |
Sector | Technology | Technology |
52-Week High | $117.75 | $310.00 |
52-Week Low | $82.26 | $211.49 |
Enterprise Value | $14.36B | $26.50B |
Dividend Yield | 0.26% | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
